News | March 23, 2009

CircuLite Presents Chronic Hemodynamic Data for Synergy Micro-Pump for Chronic Heart Failure at ACC

March 23, 2009 - CircuLite Inc. said Daniel Burkhoff, M.D., Ph.D., CircuLite’s chief medical officer and adjunct associate professor of medicine at Columbia University Medical School, will present an abstract detailing long-term hemodynamic data on the Synergy Pocket Micro-Pump in a late-breaking session at the 58th Annual Scientific Session of the American College of Cardiology March 28-31 in Orlando, FL.

Synergy is a micro-blood pump, the size of a AA battery that can be implanted superficially in a “pacemaker-like” pocket. Synergy is the first and smallest device designed for partial circulatory support (up to 3L/min) and long-term use in patients with Class IIIb and early Class IV heart failure.

Abstract number 65205 is titled, “First Proof of Long-Term Hemodynamic Benefits of Partial Ventricular Support in Patients with Severe Heart Failure,” and will be presented , from 8:15-8:25 a.m. EDT Monday, March 30. The presentation will take place in Hall A2 of the Orange County Convention Center as part of session number 407, Late-Breaking Clinical Trials III – Emerging Technologies.

The company is also participating in a Texas Heart Institute satellite symposium focused on mechanical support. This symposium, titled, “Heart Failure: Surgical and Interventional Breakthroughs in Current Practice,” will take place from 8 a.m. to noon Saturday, March 28 at The Peabody Hotel in Orlando.

The company said the Synergy Pocket Micro-Pump represents a new approach to mechanical circulatory support that can transform chronic heart failure management by providing a less-invasive, elective treatment option for patients before their disease state becomes emergent. Synergy is the first implantable system designed to provide partial circulatory support (PCS) for long-term use in millions of unserved patients that have NYHA Class IIIb/early IV disease. The devices is currently only available for investigational use in the U.S.

CircuLite’s patented micro-pump provides up to 3L/min of flow, which increases total cardiac output, offloads the heart, allowing it to rest, and potentially enables beneficial recovery of heart function. The size of a AA battery, the device is small enough to be implanted subcutaneously in a “pacemaker-like” pocket through a minimally-invasive procedure.

For more information:

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Overlay Init